Invention Grant
- Patent Title: Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
-
Application No.: US16001549Application Date: 2018-06-06
-
Publication No.: US10239911B2Publication Date: 2019-03-26
- Inventor: Jean-Pierre Sommadossi , Adel Moussa
- Applicant: Atea Pharmaceuticals, Inc.
- Applicant Address: US MA Boston
- Assignee: Atea Pharmaceuticals, Inc.
- Current Assignee: Atea Pharmaceuticals, Inc.
- Current Assignee Address: US MA Boston
- Agency: Knowles Intellectual Property Strategies, LLC
- Main IPC: A61K31/7076
- IPC: A61K31/7076 ; C07H19/207 ; C07H19/16 ; C07H19/20
Abstract:
A compound of the structure: or a pharmaceutically acceptable salt or composition thereof for the treatment of a host infected with or exposed to an HCV virus or other disorders more fully described herein.
Public/Granted literature
Information query
IPC分类:
